Cochlear | COH - Umlaufvermögen

Aktienkurs
95.25
Täglich Wechseln
-2.10 -2.16%
Monatlich
-42.94%
Jährlich
-64.51%
Q2 Prognose
95.52




Umlaufvermögen Veränderung Datum
Ansell USD 1.11B 5.2M 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Cochlear AUD 1.37B 43.9M 2025-12
CSL USD 11.85B 1000K 2025-12
Fisher Paykel Healthcare NZD 983.7M 48.3M 2025-12
Healius AUD 1.04B 737.9M 2024-12
Integral Diagnostics AUD 74.82M 9.15M 2024-06
Mayne Pharma AUD 460.59M 14.71M 2024-06
Mesoblast USD 202.48M 1.87M 2025-12
Monash IVF AUD 43.96M 2.28M 2025-12
Nanosonics AUD 234.13M 8.81M 2025-12
Polynovo AUD 69.23M 7.87M 2025-12
Ramsay Health Care AUD 3.56B 480.3M 2025-12
Regis Healthcare AUD 246.76M 6.2M 2025-12
ResMed USD 3.82B 193.06M 2025-12
Sigma Healthcare AUD 2.91B 2B 2025-12
Somnomed AUD 27.5M 4.99M 2023-06
Sonic Healthcare AUD 2.3B 52.76M 2024-12
Telix Pharmaceuticals AUD 330.28M 67.73M 2025-12